True Vision MN’s CME Group CME Stock Holding History

True Vision MN’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,853	Closed	-$400K	–	96
2023 Q4	$400K	Buy	+1,853	New	+$395K	0.32%	72

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

True Vision MN's CME Position: Q1 2024 in Review

True Vision MN sold out of CME Group (CME) in Q1 2024, closing a stake of 1,853 shares — an estimated $400K sold.

True Vision MN first reported a position in CME in Q4 2023 and held it in 1 quarter. The position peaked at $400K in Q4 2023. 1,372 funds tracked by Wall St. Rank hold CME as of Q1 2024.

True Vision MN reported no remaining CME Group position as of Q1 2024 after selling out during the quarter.
True Vision MN sold 1,853 CME Group shares in Q1 2024, an estimated $400K.
True Vision MN first reported a position in CME Group in Q4 2023 and held it in 1 quarter.
True Vision MN's CME Group position peaked at $400K in Q4 2023.
1,372 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on True Vision MN's 13F filing for Q1 2024, filed 30 Apr 2024.